New drug trial offers hope for tough blood cancers
Disease control
Recruiting now
This early-stage study is testing a new drug called RPT1G in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have returned or not responded to standard treatments. The main goals are to find out if the drug is safe, what side effects i…
Phase: PHASE1 • Sponsor: Remedy Plan, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC